Similar Papers

Paper Title
Journal
Date
Author
Abstract P2-13-02: COBRA: Characteristics and Outcomes of patients with BReast cancer in phAse I trials at Gustave Roussy Cancer center
Lauren Seknazi ...
Cancer Research | VOL. 83
Lauren Seknazi, et. al.Lauren Seknazi ...
01 Mar 2023
Abstract PO-030: Outcome of older cancer patients infected with Covid19 at Gustave Roussy Cancer Center
Mathilde Hauchecorne ...
Clinical Cancer Research | VOL. 26
Mathilde Hauchecorne, et. al.Mathilde Hauchecorne ...
15 Sep 2020
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.
Kathryn C Arbour ... Hira Rizvi
Journal of clinical oncology : official journal of the American Society of Clinical Oncology | VOL. 36
Kathryn C Arbour, et. al.Kathryn C Arbour ... Hira Rizvi
20 Aug 2018
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.
Arnaud Bayle ... Laurence Albiges
Cancer Cell | VOL. 39
Arnaud Bayle, et. al.Arnaud Bayle ... Laurence Albiges
18 Jun 2021
View more papers

More From: ESMO Open

Paper Title
Journal
Date
Author
An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations.
K.H Kim ... H.S Kim
ESMO open | VOL. 10
K.H Kim, et. al.K.H Kim ... H.S Kim
01 Feb 2025
Psychiatric disorders in adolescent and young adult cancer survivors in Korea.
S.-M Jeong ... D.W Shin
ESMO open | VOL. 10
S.-M Jeong, et. al.S.-M Jeong ... D.W Shin
01 Feb 2025
Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE).
P.G Casali ... Malvika Vyas
ESMO open | VOL. 10
P.G Casali, et. al.P.G Casali ... Malvika Vyas
01 Feb 2025
Molecular characterization of HER2-negative breast cancers reveals a distinct patient subgroup with 17q12 deletion and heterozygous loss of ERBB2.
X Qiu ... R Jeselsohn
ESMO open | VOL. 10
X Qiu, et. al.X Qiu ... R Jeselsohn
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.